Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment.
Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment.
复制标题
DOI:
10.1038/s41598-017-10940-8
复制
发表时间:
2017-09-05
影响因子:
4.6
通讯作者:
Brentjens RJ
中科院分区:
文献类型:
--
作者:
Yeku OO;Purdon TJ;Koneru M;Spriggs D;Brentjens RJ
Chimeric antigen receptor (CAR) T cell therapy has shown limited efficacy for the management of solid tumor malignancies. In ovarian cancer, this is in part due to an immunosuppressive cytokine and cellular tumor microenvironment which suppresses adoptively transferred T cells. We engineered an armored CAR T cell capable of constitutive secretion of IL-12, and delineate the mechanisms via which these CAR T cells overcome a hostile tumor microenvironment. In this report, we demonstrate enhanced proliferation, decreased apoptosis and increased cytotoxicity in the presence of immunosuppressive ascites. In vivo, we show enhanced expansion and CAR T cell antitumor efficacy, culminating in improvement in survival in a syngeneic model of ovarian peritoneal carcinomatosis. Armored CAR T cells mediated depletion of tumor associated macrophages and resisted endogenous PD-L1-induced inhibition. These findings highlight the role of the inhibitory microenvironment and how CAR T cells can be further engineered to maintain efficacy.
登录
查看更多内容
影响因子:
11.5
作者:
Kershaw, Michael H.;Westwood, Jennifer A.;Hwu, Patrick
通讯作者:
Hwu, Patrick
影响因子:
2.1
作者:
Davila ML;Bouhassira DC;Park JH;Curran KJ;Smith EL;Pegram HJ;Brentjens R
通讯作者:
Brentjens R
影响因子:
5.7
作者:
Kim S;Kim B;Song YS
通讯作者:
Song YS
影响因子:
46.9
作者:
Doench JG;Fusi N;Sullender M;Hegde M;Vaimberg EW;Donovan KF;Smith I;Tothova Z;Wilen C;Orchard R;Virgin HW;Listgarten J;Root DE
通讯作者:
Root DE
影响因子:
20.3
作者:
Duluc, Dorothee;Delneste, Yves;Jeannin, Pascale
通讯作者:
Jeannin, Pascale